about
Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosisEffect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out miceIsolation and characterization of human apolipoprotein M-containing lipoproteinsShotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDLApolipoprotein MEndothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein MProposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesisHydrophobic ligand binding properties of the human lipocalin apolipoprotein MAPOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema.Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replicationLocalized-statistical quantification of human serum proteome associated with type 2 diabetesIdentification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping dataApolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with LupusDetermination of single-nucleotide polymorphism in the proximal promoter region of apolipoprotein M gene in coronary artery diseasesApolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes.A retained secretory signal peptide mediates high density lipoprotein (HDL) assembly and function of haptoglobin-related protein.Expression and localization of apolipoprotein M in human colorectal tissuesApolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart.Apolipoprotein M T-778C polymorphism is associated with serum lipid levels and the risk of coronary artery disease in the Chinese population: a meta-analysis.Effects of simvastatin on apolipoprotein M in vivo and in vitro.Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.Comparative analysis of serum proteomes: Identification of proteins associated with sciatica due to lumbar intervertebral disc herniation.TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells.Common variants at the promoter region of the APOM confer a risk of rheumatoid arthritisSources, metabolism, and regulation of circulating sphingosine-1-phosphateApoM Suppresses TNF-α-Induced Expression of ICAM-1 and VCAM-1 Through Inhibiting the Activity of NF-κBHyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway.The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles.Meta-Analysis on the Correlation Between APOM rs805296 Polymorphism and Risk of Coronary Artery Disease.Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.Apolipoprotein M: progress in understanding its regulation and metabolic functions.The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosisIncreased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases.The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo.Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes.Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.
P2860
Q24299006-E43629D4-0611-473C-8CFE-20E12C476939Q24300591-C5F6A91E-6A8C-4BB2-B955-B163066AC0E7Q24336276-788F41BB-AEE9-45C6-80E9-F54F9FB5951FQ24669594-3DBC5AFC-C4AC-4282-BE11-76433B685292Q24802871-7710B1A1-2403-45D5-8DE8-0B41B11BBAFBQ27667968-AE011CC0-4EC1-47DB-BA2C-0A1BA2670BDEQ28202800-76BC3729-3396-453B-9EA7-4F3A21DD6C25Q28303846-3EC18CFE-473C-4855-B035-B9059AB483FCQ28387051-60E14614-144A-4706-A9B9-0D36D45EEBF5Q28740406-626DA20E-5831-4FFD-A132-D66CC2B58A26Q33369848-984EE704-0715-4403-BEDA-B1ACA4D738F8Q33399896-48568F92-45D3-4690-9C4D-A7C83642E6E6Q33634131-0A9FD481-44B5-4769-BBDF-A0BCA0A99F2FQ33644604-788F4320-0883-4353-ADC2-8FFA4ECCA21AQ33735018-92358375-3CA3-4983-B3EF-A89668917237Q33842261-CFA4E226-2B1E-4018-AA4E-1FDB2AAC0E29Q34138923-79017563-C223-42F2-8A97-9CD7CC2A3C38Q34156880-A41698C7-2F84-44B0-977C-539A7C0B8162Q34322165-0C768819-5CE5-4F4A-B4E2-56C238E8DCB1Q34336370-A410C8E8-3188-4D80-B9D5-0914FB13705FQ34563979-F54A9AD7-FE07-4894-8877-27A02F927D49Q34990747-BBD8DD94-CF99-4000-9461-63E78592E843Q35121822-0EBB4678-6A78-4D7B-9817-381845448159Q35199447-EA6B3B59-1088-4C49-99B7-B4063A5B0A88Q35211461-E22BD7BC-0162-458C-AFEB-DCCF9496CD8DQ35560513-DCE55056-E7C3-4062-8A33-2C48F4165831Q35645759-7871E4C9-088A-456F-AEFD-F6A828C233ACQ35776618-38181C21-BC90-4B15-B236-A8B8EED696A0Q35910652-037D39F3-2613-4D1F-AC75-225E02298225Q36070901-D5FA74DB-DD28-4088-BC0D-F9DF564ACAEEQ36213916-C0568C23-F404-41A0-B83E-E2335B152AB8Q36434054-42E42E59-FD2D-4712-A963-FE5859EF50EDQ36503047-40B3023A-E782-4806-B036-38DB296905AAQ36527148-57054DC3-E974-40C6-8AEE-6C3C27C58D1FQ36652565-94A5F488-99DE-4DF7-A9F0-6F0BE6C21723Q36790267-2E82DD27-ED8A-4A0C-8738-B09DC48AF381Q36823348-0D822240-49FA-4CD0-8135-39DD241B7596Q36859049-A1C3CEED-879A-4A00-994B-95E4739ACCCDQ36925831-761447F5-DEC2-4B69-AB82-1C494295C17BQ36942346-940E8B2E-C04D-45D6-8EFF-FC0FED4C902F
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
A novel human apolipoprotein (apoM)
@ast
A novel human apolipoprotein (apoM)
@en
A novel human apolipoprotein (apoM)
@en-gb
A novel human apolipoprotein (apoM)
@nl
type
label
A novel human apolipoprotein (apoM)
@ast
A novel human apolipoprotein (apoM)
@en
A novel human apolipoprotein (apoM)
@en-gb
A novel human apolipoprotein (apoM)
@nl
prefLabel
A novel human apolipoprotein (apoM)
@ast
A novel human apolipoprotein (apoM)
@en
A novel human apolipoprotein (apoM)
@en-gb
A novel human apolipoprotein (apoM)
@nl
P2860
P3181
P356
P1476
A novel human apolipoprotein (apoM)
@en
P2860
P304
P3181
P356
10.1074/JBC.274.44.31286
P407
P577
1999-10-29T00:00:00Z